I'd go for LTUS instead.. they are very well managed and have good infrastructure for their late-stage product development pipeline and good sales network. Right now the upside potential is huge if LTUS gets uplisted...They are looking for directors to add with uplisting experience according to today's PR, which caused a brief 16 percent spike in LTUS stock price at noon today. Note also they just got a patent approved 3 or 4 days ago for a diabetes drug.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.